USFDA warns Indoco over non-compliance in Goa plant

Pharma company Indoco Remedies said on Monday it has received a warning letter from the United States Food and Drug Administration (USFDA) for its oral dosages plant in Goa as a result of the inspection carried out in January.

Centaur Pharma’s Pune facility passes USFDA audit

USFDA finds zero 483 observations and grants NAI to Centaur Pharmaceutical’s finished dosage facility in Pune Mumbai based Centaur Pharmaceuticals’ finished dosage facility in Pune was audited by the USFDA in May 2019 and the audit was concluded with NIL…